After being stagnant since 2022, the Biotech sector now shows renewed growth. Biotech ETF (XBI) has outperformed the S&P 500. So, perhaps it's time for cautious optimism for investors, acquirers, and innovators. Quiet Comeback Biotech ETF has grown 5% in the last month compared to the 0.2% growth of the S&P 500. This might not … Continue reading Biotech Sector, Investor confidence, Cautious optimism